These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 26903468)

  • 21. Treatment-resistant severe, active Graves' ophthalmopathy successfully treated with B lymphocyte depletion.
    El Fassi D; Nielsen CH; Hasselbalch HC; Hegedüs L
    Thyroid; 2006 Jul; 16(7):709-10. PubMed ID: 16889501
    [No Abstract]   [Full Text] [Related]  

  • 22. [Graves' dermopathy on the big toe].
    Couderc E; Cante V; Renaud O; Guillet G
    Ann Dermatol Venereol; 2013 May; 140(5):382-5. PubMed ID: 23663712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A treatment strategy for Graves' orbitopathy.
    Marcocci C; Pinchera A; Marinò M
    Nat Clin Pract Endocrinol Metab; 2007 May; 3(5):430-6. PubMed ID: 17452970
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thyroid Orbitopathy.
    Wang Y; Tooley AA; Mehta VJ; Garrity JA; Harrison AR; Mettu P
    Int Ophthalmol Clin; 2018; 58(2):137-179. PubMed ID: 29517649
    [No Abstract]   [Full Text] [Related]  

  • 25. [Therapy of endocrine ophthalmopathy].
    Pfannenstiel P; Utech C; Wulle KG
    Dtsch Med Wochenschr; 1986 Aug; 111(35):1331-3. PubMed ID: 3755678
    [No Abstract]   [Full Text] [Related]  

  • 26. B-cell targeted therapy with rituximab for thyroid eye disease: closer to the clinic.
    Shen S; Chan A; Sfikakis PP; Hsiu Ling AL; Detorakis ET; Boboridis KG; Mavrikakis I
    Surv Ophthalmol; 2013; 58(3):252-65. PubMed ID: 23253433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thyroid-associated orbitopathy: who and how to treat.
    Dickinson J; Perros P
    Endocrinol Metab Clin North Am; 2009 Jun; 38(2):373-88, ix. PubMed ID: 19328417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined thyroid eye clinic: the importance of a multidisciplinary health care in patients with Graves' orbitopathy.
    Wiersinga WM
    Pediatr Endocrinol Rev; 2010 Mar; 7 Suppl 2():250-3. PubMed ID: 20467372
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Management of Graves' orbitopathy: evidence-based recommendations].
    Ponto KA; Pitz S; Mann WJ; Weber MM; Pfeiffer N; Kahaly GJ
    Dtsch Med Wochenschr; 2009 Dec; 134(49):2521-4. PubMed ID: 19941237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study of serum antibodies against three eye muscle antigens and the connective tissue antigen collagen XIII in patients with Graves' disease with and without ophthalmopathy: correlation with clinical features.
    Gopinath B; Musselman R; Adams CL; Tani J; Beard N; Wall JR
    Thyroid; 2006 Oct; 16(10):967-74. PubMed ID: 17042681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strabismus associated with thyroid eye disease.
    Schotthoefer EO; Wallace DK
    Curr Opin Ophthalmol; 2007 Sep; 18(5):361-5. PubMed ID: 17700227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Therapeutic effect and side effect of treatment on hyperthyroid exophthalmos with the combination of acupuncture and medication].
    Xia Y; Shu S; Li Y; Liu SM; He JS
    Zhongguo Zhen Jiu; 2010 Oct; 30(10):806-9. PubMed ID: 21058474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pemphigus vulgaris: approach to treatment.
    Sinha AA; Hoffman MB; Janicke EC
    Eur J Dermatol; 2015 Apr; 25(2):103-13. PubMed ID: 25547117
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Management of Graves' ophthalmopathy].
    Schalin-Jäntti C
    Duodecim; 2010; 126(20):2431-7. PubMed ID: 21125757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Orbit and orbital apex.
    Robinson D; Wilcsek G; Sacks R
    Otolaryngol Clin North Am; 2011 Aug; 44(4):903-22, viii. PubMed ID: 21819879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of corticosteroids and external beam radiation in the management of moderate to severe thyroid eye disease.
    Zoumalan CI; Cockerham KP; Turbin RE; Volpe NJ; Kazim M; Douglas RS; Feldon SE
    J Neuroophthalmol; 2007 Sep; 27(3):205-14. PubMed ID: 17895822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The diagnosis and treatment of thyroid-associated ophthalmopathy.
    Gould DJ; Roth FS; Soparkar CN
    Aesthetic Plast Surg; 2012 Jun; 36(3):638-48. PubMed ID: 22083413
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapy: evidence-based treatment of Graves ophthalmopathy.
    Wiersinga WM
    Nat Rev Endocrinol; 2009 Dec; 5(12):653-4. PubMed ID: 19924152
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of thyroid ophthalmopathy with corticoid analogues.
    HALES IB; THOMAS ID
    Australas Ann Med; 1962 May; 11():113-7. PubMed ID: 13903812
    [No Abstract]   [Full Text] [Related]  

  • 40. Cohort study on radioactive iodine-induced hypothyroidism: implications for Graves' ophthalmopathy and optimal timing for thyroid hormone assessment.
    Stan MN; Durski JM; Brito JP; Bhagra S; Thapa P; Bahn RS
    Thyroid; 2013 May; 23(5):620-5. PubMed ID: 23205939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.